Amna Nawaz
@PBSNewsHour·5.3M subscribers·62.2K videos
New law caps insulin prices for some with diabetes, but cost remains high for others
Posted
January 17, 2024
Views
6,525
Likes
122
Engagement
1.87%
January 17, 2024
6,525
122
1.87%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
8:26Now PlayingDiabetics will now see a break in their out-of-pocket costs for insulin. Sanofi, one of the leading manufacturers of the hormone, joined two other major pharmaceutical companies in capping their insulin copays at $35. This comes after years of pressure by President Biden, lawmakers and activists for companies to lower their list prices. White House Correspondent Laura Barrón-López reports.
Stream your PBS favorites with the PBS app
Find more from PBS NewsHour at
Subscribe to our YouTube channel
Subscribe:
PBS NewsHour podcasts
Newsletters
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
